Camilla Ingrid Hatleberg

Cardiovascular disease and use of contemporary protease inhibitors: the D:A:D international prospective multicohort study

Lene Ryom, Jens Lundgren, Wafaa El‐Sadr et al. · The Lancet HIV · 2018 · 220 citations · Full text

Medicine, Cardiology, Pharmacotherapy +15

Incidence of hypertension in people with HIV who are treated with integrase inhibitors versus other antiretroviral regimens in the RESPOND cohort consortium

Dathan M. Byonanebye, Mark N. Polizzotto, Bastian Neesgaard et al. · HIV Medicine · 2022 · 65 citations · Full text

Public Health, Internal Medicine, Pharmacotherapy +17

Body Mass Index and the Risk of Serious Non-AIDS Events and All-Cause Mortality in Treated HIV-Positive Individuals: D:A:D Cohort Analysis

Amit C. Achhra, Caroline Sabin, Lene Ryom et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2018 · 53 citations

Public Health, Health Sciences, Clinical Epidemiology +14

Renal Impairment and Cardiovascular Disease in HIV-Positive Individuals: The D:A:D Study

Lene Ryom, Jens Lundgren, Mike Ross et al. · The Journal of Infectious Diseases · 2016 · 49 citations · Full text

Medicine, Internal Medicine, Nephrology +17

Cardiovascular disease (CVD) and chronic kidney disease (CKD) event rates in HIV-positive persons at high predicted CVD and CKD risk: A prospective analysis of the D:A:D observational study

Mark Boyd, Amanda Mocroft, Lene Ryom et al. · PLoS Medicine · 2017 · 31 citations · Full text

Medicine, Nephrology, Clinical Epidemiology +16